An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson’s Disease and Depression

BACKGROUND: Many patients with Parkinson’s disease (PD) experience depression. OBJECTIVE: Evaluate pimavanserin treatment for depression in patients with PD. METHODS: Pimavanserin was administered as monotherapy or adjunctive therapy to a selective serotonin reuptake inhibitor or serotonin/noradrena...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Parkinsons Dis
Asıl Yazarlar: DeKarske, Daryl, Alva, Gustavo, Aldred, Jason L., Coate, Bruce, Cantillon, Marc, Jacobi, Lori, Nunez, Rene, Norton, James C., Abler, Victor
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: IOS Press 2020
Konular:
Research Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683094/
https://ncbi.nlm.nih.gov/pubmed/32804101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-202058
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller